Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

The Siah1 and Siah2 genes are active in mouse skin development and hair growth, especially right after birth.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Finasteride helps female-pattern hair loss.

β-catenin is essential for stem cell activation and proliferation in hair follicles.

HairMax LaserComb® effectively promotes hair growth and stops hair loss in males with androgenetic alopecia, with no serious side effects.

No treatment fully prevents hair loss from chemotherapy yet.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Pitx2 helps outer root sheath cells differentiate but can't start hair growth on its own.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Finasteride increases hair count in middle-aged and elderly men without causing sexual dysfunction.

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Rabbit skin analysis showed changes in hair growth and identified miRNAs that may regulate hair follicle development.

Norgalanthamine helps hair cells grow by activating certain pathways related to hair growth.

Impaired autophagy may cause hair loss by triggering early catagen.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Stem cell therapy shows promise for treating hair loss in androgenetic alopecia.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Laser treatment shows promise for hair growth, but needs further research.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Skin stem cells are crucial for maintaining and repairing the skin and hair, using a complex mix of signals to do so.